Pablo Barth

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Department of Biochemistry, University Medical School, Bialystok, Poland; Microbiology Department, Glaxo Research Ltd., Greenford, Middlesex, England; Department of Bacteriology, Royal Postgraduate Medical School, London, W12 OHS, England*; Department of Clinical Therapeutics, School of Medicine, University of Athens, Alexandra Hospital, Athens, Greece; and(More)
A clinical study was carried out in 20 patients in coronary angiography to compare two low-osmolar contrast media, sodium-meglumine ioxaglate and iopromide. Ten patients presented a stage III coronary disease and the other ten had a stage IV coronary disease. In the latter group, 70% of the patients received sodium-meglumine ioxaglate and 30% were given(More)
  • 1